Fundraising Fox
XEIA Venture Partners
Venture capitalActively deployingSan Francisco · 3 people tracked
Also known as XEIA
Find your way into XEIA Venture Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Chris Minar to introduce you to Sam Rector
You →Chris · together at National Institutes of Health →Sam
Ask Jamie Chen to introduce you to Brom Rector
You →Jamie · together at Crabel Capital Management, LLC →Brom
Ask Sam Okafor to introduce you to Arye Lipman
You →Sam · together at imec →Arye
Sign up to find every way you can get introduced to XEIA Venture Partners
- Your email: who you already know at XEIA Venture Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the XEIA Venture Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
XEIA Venture Partners pursues cross-disciplinary exploration, investment and acceleration, organized around a 'Human 3' theme concerning the future of health, wellbeing and performance. The firm backs early-stage startups and is notably open to founding teams that are romantic couples, having found several such teams among its highest-performing portfolio companies in its first fund. It invested in roughly 11 companies across 2024 and the first half of 2025 and has raised a first fund plus a first close on a second fund.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & curatedWhat they invest in
from 16 of 31 portfolio companiesBiotech ×11Deep Tech ×8Healthtech ×8Medical Devices ×5AI & Machine Learning ×4Digital Health ×4Mental Health ×4Longevity ×2
HQs:United States×10Australia×2Mexico×1
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×32 founders×53 founders×1
Where their founders studiedfrom 10 founders with education data
Massachusetts Institute of Technology ×2University of Cambridge ×2
What their founders studiedfrom 11 founders with field-of-study data
Engineering ×4Life Sciences ×4Business & Management ×2
Where their founders worked beforefrom 10 founders with career history
Stanford University ×2
Investments · 31 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 42024 · 22021 · 18 dated
Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull.
Deep TechHealthtechMedical Devices
José Morales(Dr.)
Co-investorsSmartGateVC
Aperture Therapeutics uses machine learning to mine genomic and clinical datasets for naturally occurring protective gene variants, then designs oligonucleotide therapeutics that mimic those variants to treat neurodegenerative diseases such as ALS and FTD and delay brain aging.
AI & Machine LearningBiotechLongevity
Martin Jacko(Founder & CEO)in
Co-investorsage1
Beond operates a medically supervised ibogaine treatment facility in Mexico that uses neuroplasticity-focused therapies to treat depression, anxiety, PTSD, trauma, TBI, and substance addictions such as opioids, fentanyl, stimulants, and alcohol use disorder.
HealthtechMental HealthWellness & Fitness
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in
Co-investorsArtesianBlackbird FoundryBlackbird VenturesDivergent CapitalPossible VenturesSmartGateVC+3 more
The page references health, wellbeing and performance under the banner "Human 3," alongside expertise in AI/ML, medicinal chemistry/pharmacology, and aging-brain research.
AI & Machine LearningLongevityWellness & FitnessSan Francisco, US
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.
BiotechDeep TechMental Health
Co-investorsJourneyOne VenturesLauder PartnersLeafy TunnelSolari CapitalWGD Capital, L.P.
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US
Dillan DiNardo(Founder/CEO)inTom Ray(Founder)in
BoardRand Hindi(Director)in
Co-investorsImmeasurableInitialized CapitalMetaplanetNegev CapitalPsyMed VenturesY Combinator+11 more
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)in
BoardJacob Robinson(Co-founder & CEO)in
Co-investorsArboretum VenturesDivergent CapitalDolby Family VenturesFeatures Capital HoldingsPsyMed VenturesTMC Venture Fund+4 more
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)in
Co-investorsDolby Family VenturesFuture VenturesGreyMatterPioneerVanedge CapitalVanedge Capital Limited Partnership+1 more
Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity.
BiotechDeep TechDigital Health
Co-investorsMetaplanetNO LABEL VENTURESPalo Santo VCSeaside VenturesVox Capital
Platform accelerating drug discovery for untreatable diseases.
BiotechDedham, US
Samantha Dale Strasser(Director)Jon (Yu) Hu(Founder)inYu Hu(Executive Officer, Director)
BoardOmri Amirav-Drory(Director)in
Co-investorsbig_betsSilverton PartnersB Capital GroupMana VenturesNFXVSC Ventures
.jpeg){kind=logo}
TARA Mind offers a specialized, clinician-guided mental health benefit that employers add to their existing benefits to serve workers with treatment-resistant conditions, connecting them to a vetted U.S. network of therapists and physicians for evidence-based care.
Digital HealthHR TechMental Health
Marcus Capone(Founder & CEO)in
Co-investorsRed Cell IncubationPrime Movers Lab
TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.
BiotechDeep TechHealthtechSan Francisco, US
Laura Hsieh(Founder & CEO)in
Co-investorsFREEFLOWBrightEdgeSazzeSOSVStoryHouse
Ultra Bionics develops implantable focused ultrasound technology placed inside the skull to deliver targeted, adaptive neuromodulation for treating neurological diseases, beginning with Parkinson's disease.
Deep TechHealthtechMedical DevicesMelbourne, AU
Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches.
BiotechDeep TechDigital HealthHealthtechSydney, AU
Joshua Ismin(Co-founder, President)inDr. Sam Banister(Co-founder, Chief Scientific Officer)
Co-investorsPalo Santo VCRadar VenturesTenmileCapitalTCommon MagicSure Valley Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ApertureBeondBiosphereForecast BioFreedomKadenceKerna LabsLykosMotifMycrodose TherapeuticsPangeaPodcastSuperpowerSynchronTippingPointWonder
Portfolio news
latest coverage across their companiesTippingPoint Biosciences · trysignalbase.com · Apr 2, 2026
NeuroBionics · neurobionics.io · Dec 16, 2025
Frequently asked questions
- How many investments has XEIA Venture Partners made?
- XEIA Venture Partners has 31 tracked investments, including 6 dated in the last 24 months.
- What sectors does XEIA Venture Partners focus on?
- XEIA Venture Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Longevity, Wellness & Fitness.
- Where is XEIA Venture Partners located?
- XEIA Venture Partners is headquartered in San Francisco, US.
- Who does XEIA Venture Partners co-invest with?
- XEIA Venture Partners most often shares deals with Dolby Family Ventures, Metaplanet, PsyMed Ventures, among 31 tracked co-investors.
Images
Co-investors · 2
Investment firm focused on emerging public and private companies in agriculture, consumer, healthcare, and technology sectors, leveraging deep expertise in small-cap markets.
Four Acres is an early-stage venture capital fund founded by native New Yorkers, focused on software-first technology companies.
Firms observed investing alongside XEIA Venture Partners, from public investor directories. Shared companies are the overlap with XEIA Venture Partners's recorded portfolio.
Similar investors
Lauder Partners, LLC is a technology-focused investment entity that invests both directly in companies and in funds (venture and other), primarily deploying the capital of Gary Lauder and his family.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Anthropy Partners is an investment firm backing founders building technologies that extend the capabilities of the human body and mind, focused on what it calls the 'long-human era'.
Embryo Ventures is an early-stage venture firm backing founders building technologies across human health and human experience, from clinical and consumer health to essential life infrastructure.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.